CureDM

CureDM is a biopharmaceutical company that provides therapies to treat diabetes. It develops Human proIslet Peptide (HIP), a peptide associated with the regeneration of insulin-producing islets within the pancreas. The company aims to restore, maintain, and protect insulin-producing islet structures in patients with diabetes.